...
首页> 外文期刊>Biopharmaceutics and Drug Disposition >Increased membrane permeation and blood concentration of 6‐carboxyfluorescein associated with dysfunction of paracellular route barrier in the small intestine of ulcerative colitis model rats
【24h】

Increased membrane permeation and blood concentration of 6‐carboxyfluorescein associated with dysfunction of paracellular route barrier in the small intestine of ulcerative colitis model rats

机译:增加了与溃疡性结肠炎模型大鼠小肠中肺膜路径屏障功能障碍相关的6-羧基荧光素的膜渗透和血液浓度

获取原文
获取原文并翻译 | 示例

摘要

Abstract In the colon of patients with ulcerative colitis (UC), decreased function of the paracellular barrier, especially hypofunction of the tight junction, is associated with pathological conditions. However, there has been no report to date on the function of tight junctions in the small intestine. Here, we focused on the barrier function of the small intestine, especially in tight junctions, and compared it with that of the colon. Dextran sulfate sodium (DSS) was used to induce ulcerative colitis in rats in order to evaluate the function of the paracellular barrier in the jejunum, ileum, and colon. An in vitro diffusion chamber method was used to evaluate membrane resistance, which is an index of tight junction function and mucosal permeability, using 6‐carboxyfluorescein (6‐CF), a paracellular marker. In the jejunum and colon, with decrease of membrane resistance in the DSS group, mucosal permeability increased, whereas no marked difference was observed in the ileum. In the in situ closed‐loop method, absorption of 6‐CF from the jejunum was higher than that from the ileum. Immunohistochemical staining of claudin‐4 showed heterogeneous attenuation of claudin‐4 in the jejunum. Pharmacokinetic parameters were calculated from the blood concentration after intravenous injection and oral administration of 6‐CF. In the DSS group, there was a delay in the elimination phase, suggesting a decrease in renal function, and an increase in maximum blood concentration, associated with an increased absorption rate constant. The increased absorption and decreased renal function due to decreased paracellular barrier function in the small intestine and colon may cause fluctuations in drug efficacy and side effects.
机译:摘要在溃疡性结肠炎(UC)的患者的结肠中,降低静脉屏障的功能,特别是紧密结的紊乱,与病理条件有关。但是,迄今为止没有报告小肠的紧密交界的功能。在这里,我们专注于小肠的屏障功能,尤其是在紧密的连接中,并将其与结肠的结合。葡聚糖硫酸钠钠(DSS)用于在大鼠中诱导溃疡性结肠炎,以评估Jejunum,Hileum和Colon中的锥虫屏障的功能。使用6-羧基荧光蛋白(6-CF),肺结泡标记,用于评估膜抗性的膜抗性,即粘膜抗性和粘膜渗透性。在Jejunum和结肠中,随着DSS组的膜抗性的降低,粘膜渗透率增加,而Ileum中没有观察到明显的差异。在原位闭环法中,来自Jejunum的6-CF的吸收高于回肠。克劳丁蛋白-4的免疫组织化学染色显示了Jejunum的克劳德蛋白-4的异质衰减。从静脉注射后和口服施用6-CF后从血液浓度计算药代动力学参数。在DSS组中,消除阶段存在延迟,表明肾功能下降,以及与增加的吸收率恒定相关的最大血液浓度增加。由于小肠和结肠减少的静脉阻隔功能降低,肾功能增加的吸收和降低可能导致药物疗效和副作用的波动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号